UMass Med uses genomic sequencing to detect COVID-19 mutations
We know the highly transmissible U.K. variant of COVID-19 is here.
Now researchers at UMass Medical School are conducting genomic sequencing to determine the extent of this and other COVID variants in Central Massachusetts, an effort that could lead to more effective vaccines as well as a better understanding of the virus’ spread.
“There are two things about it,” said Dr. Richard T. Ellison III, an infectious disease specialist at UMass Medical School who is leading the research in collaboration with the Centers for Disease Control and Prevention and the Broad Institute at Massachusetts Institute of Technology and Harvard University.